Toward a normalized clinical drug knowledge base in China-applying the RxNorm model to Chinese clinical drugs.

Journal: Journal of the American Medical Informatics Association : JAMIA
PMID:

Abstract

OBJECTIVE: In recent years, electronic health record systems have been widely implemented in China, making clinical data available electronically. However, little effort has been devoted to making drug information exchangeable among these systems. This study aimed to build a Normalized Chinese Clinical Drug (NCCD) knowledge base, by applying and extending the information model of RxNorm to Chinese clinical drugs.

Authors

  • Li Wang
    College of Marine Electrical Engineering, Dalian Maritime University, Dalian, China.
  • Yaoyun Zhang
    Alibaba Damo Academy, 969 West Wen Yi Road, Yu Hang District, Hangzhou, Zhejiang, China.
  • Min Jiang
    Eli Lilly and Company, Indianapolis, IN, United States.
  • Jingqi Wang
    School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Jiancheng Dong
    Department of Medical Informatics, Medical School, Nantong University, Nantong, Jiangsu 226001, China.
  • Yun Liu
    Google Health, Palo Alto, CA USA.
  • Cui Tao
    The University of Texas Health Science Center at Houston, USA.
  • Guoqian Jiang
    Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Yi Zhou
    Eye Center of Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Hua Xu
    Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.